Literature DB >> 30623540

Evaluation of second trimester amniotic fluid ADAMTS4, ADAMTS5, interleukin-6 and tumor necrosis factor-α levels in patients with gestational diabetes mellitus.

Rauf Melekoglu1, Osman Ciftci2, Ebru Celik3, Ercan Yilmaz1, Ayse G Bastemur1.   

Abstract

AIM: To test the hypothesis that altered A Disintegrin and Metalloproteinase Domains with Thrombospondins motifs (ADAMTS) is implicated in the etiopathogenesis of gestational diabetes mellitus (GDM).
METHODS: All pregnant women who underwent elective amniocentesis for karyotype analysis between January 1, 2016, and January 1, 2018, were included in this study. From this cohort, the study group consisting of 20 patients diagnosed with GDM was selected and compared against a control group consisting of 20 age- and body mass index (BMI)-matched patients without GDM. ADAMTS4, ADAMTS5, interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) levels were compared in the second trimester amniotic fluid of patients with GDM and normoglycemic pregnant women.
RESULTS: No significant differences were observed between GDM and control groups regarding age, BMI, gestational age at amniocentesis and indication for amniocentesis. Mean amniotic fluid ADAMTS4 and ADAMTS5 levels were significantly increased in the GDM group compared with the control group (253.5 ± 18.7 pg/mL and 188.5 ± 21.3 pg/mL, P < 0.001; 192.9 ± 16.4 pg/mL and 154.8 ± 19.9 pg/mL, P = 0.021, respectively). Significant increases in IL-6 and TNF-α levels were also detected in the amniotic fluid of GDM patients relative to controls (136.2 ± 17.3 pg/mL and 98.3 ± 11.5 pg/mL, P < 0.001; 154.2 ± 12.5 pg/mL and 86.2 ± 10.8 pg/mL, P < 0.001, respectively).
CONCLUSION: The data presented here suggest that increased levels of ADAMTS4, ADAMTS5, IL-6 and TNF-α may play an important role in the progression of GDM.
© 2019 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  A Disintegrin and Metalloprotease Protein; amnion; gestational diabetes mellitus; interleukin-6; thrombospondin; tumor necrosis factor-alpha

Mesh:

Substances:

Year:  2019        PMID: 30623540     DOI: 10.1111/jog.13914

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  5 in total

Review 1.  The diagnostic indicators of gestational diabetes mellitus from second trimester to birth: a systematic review.

Authors:  Amanda Henry; Alec Welsh; Daria Di Filippo; Thiyasha Wanniarachchi; Daniel Wei; Jennifer J Yang; Aoife Mc Sweeney; Alys Havard
Journal:  Clin Diabetes Endocrinol       Date:  2021-10-11

Review 2.  GDM-complicated pregnancies: focus on adipokines.

Authors:  Marta Mallardo; Sara Ferraro; Aurora Daniele; Ersilia Nigro
Journal:  Mol Biol Rep       Date:  2021-10-15       Impact factor: 2.316

3.  Expression of H2S in Gestational Diabetes Mellitus and Correlation Analysis with Inflammatory Markers IL-6 and TNF-α.

Authors:  Yucui Teng; Shuxia Xuan; Ming Jiang; Li Tian; Jinjing Tian; Qian Chang
Journal:  J Diabetes Res       Date:  2020-03-23       Impact factor: 4.011

4.  Expression and correlation of Chemerin and FABP4 in peripheral blood of gestational diabetes mellitus patients.

Authors:  Xueling Wang; Juanjuan Liu; Dongqing Wang; Honghua Zhu; Le Kang; Juan Jiang
Journal:  Exp Ther Med       Date:  2019-11-26       Impact factor: 2.447

5.  Sex Specific Expression of Interleukin 7, 8 and 15 in Placentas of Women with Gestational Diabetes.

Authors:  Simon Keckstein; Sophia Pritz; Niklas Amann; Sarah Meister; Susanne Beyer; Magdalena Jegen; Christina Kuhn; Stefan Hutter; Julia Knabl; Sven Mahner; Thomas Kolben; Udo Jeschke; Theresa M Kolben
Journal:  Int J Mol Sci       Date:  2020-10-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.